Back to AXSM
TRUIST FINANCIAL CORP AXSM Position History
Axsome Therapeutics, Inc. • Healthcare
Quarters held
10
Latest value
$533K
Q3 2026
Peak value
$533K
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $179K |
| Q3 2025 | $58K |
| Q4 2025 | $173K |
| Q4 2025 | $385K |
| Q1 2026 | $144K |
| Q1 2026 | $327K |
| Q2 2026 | $185K |
| Q2 2026 | $449K |
| Q3 2026 | $167K |
| Q3 2026 | $533K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $533K | 2.9K | — | — |
| Q3 2026 | $167K | 905 | — | — |
| Q2 2026 | $449K | 1.8K | — | — |
| Q2 2026 | $185K | 754 | — | — |
| Q1 2026 | $327K | 1.9K | — | — |
| Q1 2026 | $144K | 852 | — | — |
| Q4 2025 | $385K | 2.1K | — | — |
| Q4 2025 | $173K | 949 | — | — |
| Q3 2025 | $58K | 479 | — | — |
| Q3 2025 | $179K | 1.5K | — | — |
Other funds holding AXSM
$697.4M
$467.7M
$442.1M
$402.1M
$192.3M
$192.3M
$175M